NEW CATALYTIC AND ENANTIOSELECTIVE REACTIONS

该研究项目的主要目标是开发两种新的 不对称催化碳-碳键形成方法。 整体 目标是增加高效率和 对人类重要分子的对映选择性构建 健康护理 具有催化作用的反应，以出色的方式进行 选择性，是有效的，使用廉价的材料， 极大地缩短了一个概念的概念之间的时间跨度 治疗候选物及其大规模制备和销售。 在这方面，新的不对称催化剂的实用性， 转型将突出高效和选择性 合成几种重要的药物。 要探索的第一个反应是不对称加成 三甲基甲硅烷基氰化物到环氧化物。 初步结果显示， 这一新的转型的可行性。 后续研究将 通过方便而系统的修改来优化过程， 新型催化体系的肽基配体结构; 更好地理解反应的机理， 转化为合成各种抗HIV药物。 类似地，将三甲基甲硅烷基氰化物加成到亚胺（Strecker 反应）将发展成一般的催化不对称 转型 反应的范围将再次用 含有与肽配体配位的金属的催化剂。 反应 机制将被探索和应用到重要分子 将被证明。 这两种待开发的反应都将使用刘易斯酸性金属 其用手性肽基配体作为催化剂修饰。 的 特别重要的是新催化剂可以被 准备和优化。 这种独特而有用的功能是直接 使用氨基酸作为配体的手性结构单元的结果 系统 由于氨基酸容易获得， 在溶液和固相中同时进行 多配体结构的制备相对简单。 大量的配体，可以制备和筛选的两个 反应性和选择性，以系统的方式允许快速 选择最佳催化体系。

The primary goal of the proposed research project is to develop two new asymmetric catalytic carbon-carbon bond forming processes. The overall objective is to increase the opportunities for efficient and enantioselective construction of molecules important to human healthcare. Reactions that are catalytic, that proceed with outstanding selectivity, that are efficient and use inexpensive materials can dramatically diminish the time span between the conception of a therapeutic candidate and its large scale preparation and marketing. In this regard, the utility of the new asymmetric catalytic transformations will be highlighted with efficient and selective synthesis of several medicinally important agents. The first reaction to be explored is the asymmetric addition of trimethylsilylcyanide to epoxides. Preliminary results have shown the feasibility of this new transformation. Subsequent studies will optimize the process through convenient yet systematic modifications to the peptidyl ligand structure of the novel catalytic system; developing a better mechanistic understanding of the reaction, and applying this transformation toward the synthesis of various anti-HIV agents. Similarly, the addition of trimethylsilylcyanide to imines (Strecker reaction) will be developed into a general catalytic asymmetric transformation. Again the scope of the reaction will be delineated with catalysts containing metals coordinated to peptidic ligands. Reaction mechanism will be probed and applications toward important molecules will be demonstrated. Both of the reactions to be developed will employ Lewis acidic metals that are modified with chiral peptidyl ligands as catalysts. Of particular significance is the speed at which the new catalysts can be prepared and optimized. This unique and useful feature is the direct result of using amino acids as the chiral building blocks of the ligand system. Since amino acids are readily available and peptide synthesis has been worked out in both solution and solid phase, simultaneous preparation of multiple ligand structures is relatively straightforward. The large number of ligands that can be prepared and screened for both reactivity and selectivity in a systematic manner allows for the rapid selection of an optimal catalytic system.